Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future
Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and...
Ausführliche Beschreibung
Autor*in: |
van Karnebeek, Clara D.M. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2016 |
---|
Schlagwörter: |
---|
Umfang: |
13 |
---|
Übergeordnetes Werk: |
Enthalten in: NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS - Patterson, Tiffany ELSEVIER, 2016, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:65 ; year:2016 ; pages:1-13 ; extent:13 |
Links: |
---|
DOI / URN: |
10.1016/j.pediatrneurol.2016.07.010 |
---|
Katalog-ID: |
ELV024621870 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV024621870 | ||
003 | DE-627 | ||
005 | 20230623174418.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.pediatrneurol.2016.07.010 |2 doi | |
028 | 5 | 2 | |a GBVA2016015000027.pica |
035 | |a (DE-627)ELV024621870 | ||
035 | |a (ELSEVIER)S0887-8994(16)30195-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 600 |a 690 |q VZ |
084 | |a 51.00 |2 bkl | ||
084 | |a 51.32 |2 bkl | ||
100 | 1 | |a van Karnebeek, Clara D.M. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future |
264 | 1 | |c 2016 | |
300 | |a 13 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. | ||
650 | 7 | |a neurogenetic disorders |2 Elsevier | |
650 | 7 | |a genetic diseases |2 Elsevier | |
650 | 7 | |a therapy |2 Elsevier | |
650 | 7 | |a fragile X syndrome |2 Elsevier | |
650 | 7 | |a developmental disorders |2 Elsevier | |
700 | 1 | |a Bowden, Kristin |4 oth | |
700 | 1 | |a Berry-Kravis, Elizabeth |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Patterson, Tiffany ELSEVIER |t NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS |d 2016 |g Amsterdam [u.a.] |w (DE-627)ELV01421802X |
773 | 1 | 8 | |g volume:65 |g year:2016 |g pages:1-13 |g extent:13 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.pediatrneurol.2016.07.010 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a GBV_ILN_40 | ||
936 | b | k | |a 51.00 |j Werkstoffkunde: Allgemeines |q VZ |
936 | b | k | |a 51.32 |j Werkstoffmechanik |q VZ |
951 | |a AR | ||
952 | |d 65 |j 2016 |h 1-13 |g 13 | ||
953 | |2 045F |a 610 |
author_variant |
k c d v kcd kcdv |
---|---|
matchkey_str |
vankarnebeekclaradmbowdenkristinberrykra:2016----:ramnonuoeeidvlpetlodtosr |
hierarchy_sort_str |
2016 |
bklnumber |
51.00 51.32 |
publishDate |
2016 |
allfields |
10.1016/j.pediatrneurol.2016.07.010 doi GBVA2016015000027.pica (DE-627)ELV024621870 (ELSEVIER)S0887-8994(16)30195-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl van Karnebeek, Clara D.M. verfasserin aut Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future 2016 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Elsevier Bowden, Kristin oth Berry-Kravis, Elizabeth oth Enthalten in Elsevier Science Patterson, Tiffany ELSEVIER NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS 2016 Amsterdam [u.a.] (DE-627)ELV01421802X volume:65 year:2016 pages:1-13 extent:13 https://doi.org/10.1016/j.pediatrneurol.2016.07.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 51.00 Werkstoffkunde: Allgemeines VZ 51.32 Werkstoffmechanik VZ AR 65 2016 1-13 13 045F 610 |
spelling |
10.1016/j.pediatrneurol.2016.07.010 doi GBVA2016015000027.pica (DE-627)ELV024621870 (ELSEVIER)S0887-8994(16)30195-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl van Karnebeek, Clara D.M. verfasserin aut Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future 2016 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Elsevier Bowden, Kristin oth Berry-Kravis, Elizabeth oth Enthalten in Elsevier Science Patterson, Tiffany ELSEVIER NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS 2016 Amsterdam [u.a.] (DE-627)ELV01421802X volume:65 year:2016 pages:1-13 extent:13 https://doi.org/10.1016/j.pediatrneurol.2016.07.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 51.00 Werkstoffkunde: Allgemeines VZ 51.32 Werkstoffmechanik VZ AR 65 2016 1-13 13 045F 610 |
allfields_unstemmed |
10.1016/j.pediatrneurol.2016.07.010 doi GBVA2016015000027.pica (DE-627)ELV024621870 (ELSEVIER)S0887-8994(16)30195-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl van Karnebeek, Clara D.M. verfasserin aut Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future 2016 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Elsevier Bowden, Kristin oth Berry-Kravis, Elizabeth oth Enthalten in Elsevier Science Patterson, Tiffany ELSEVIER NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS 2016 Amsterdam [u.a.] (DE-627)ELV01421802X volume:65 year:2016 pages:1-13 extent:13 https://doi.org/10.1016/j.pediatrneurol.2016.07.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 51.00 Werkstoffkunde: Allgemeines VZ 51.32 Werkstoffmechanik VZ AR 65 2016 1-13 13 045F 610 |
allfieldsGer |
10.1016/j.pediatrneurol.2016.07.010 doi GBVA2016015000027.pica (DE-627)ELV024621870 (ELSEVIER)S0887-8994(16)30195-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl van Karnebeek, Clara D.M. verfasserin aut Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future 2016 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Elsevier Bowden, Kristin oth Berry-Kravis, Elizabeth oth Enthalten in Elsevier Science Patterson, Tiffany ELSEVIER NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS 2016 Amsterdam [u.a.] (DE-627)ELV01421802X volume:65 year:2016 pages:1-13 extent:13 https://doi.org/10.1016/j.pediatrneurol.2016.07.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 51.00 Werkstoffkunde: Allgemeines VZ 51.32 Werkstoffmechanik VZ AR 65 2016 1-13 13 045F 610 |
allfieldsSound |
10.1016/j.pediatrneurol.2016.07.010 doi GBVA2016015000027.pica (DE-627)ELV024621870 (ELSEVIER)S0887-8994(16)30195-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl van Karnebeek, Clara D.M. verfasserin aut Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future 2016 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Elsevier Bowden, Kristin oth Berry-Kravis, Elizabeth oth Enthalten in Elsevier Science Patterson, Tiffany ELSEVIER NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS 2016 Amsterdam [u.a.] (DE-627)ELV01421802X volume:65 year:2016 pages:1-13 extent:13 https://doi.org/10.1016/j.pediatrneurol.2016.07.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 51.00 Werkstoffkunde: Allgemeines VZ 51.32 Werkstoffmechanik VZ AR 65 2016 1-13 13 045F 610 |
language |
English |
source |
Enthalten in NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS Amsterdam [u.a.] volume:65 year:2016 pages:1-13 extent:13 |
sourceStr |
Enthalten in NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS Amsterdam [u.a.] volume:65 year:2016 pages:1-13 extent:13 |
format_phy_str_mv |
Article |
bklname |
Werkstoffkunde: Allgemeines Werkstoffmechanik |
institution |
findex.gbv.de |
topic_facet |
neurogenetic disorders genetic diseases therapy fragile X syndrome developmental disorders |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS |
authorswithroles_txt_mv |
van Karnebeek, Clara D.M. @@aut@@ Bowden, Kristin @@oth@@ Berry-Kravis, Elizabeth @@oth@@ |
publishDateDaySort_date |
2016-01-01T00:00:00Z |
hierarchy_top_id |
ELV01421802X |
dewey-sort |
3610 |
id |
ELV024621870 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV024621870</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623174418.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pediatrneurol.2016.07.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016015000027.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV024621870</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0887-8994(16)30195-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.32</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">van Karnebeek, Clara D.M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">13</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">neurogenetic disorders</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">genetic diseases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">fragile X syndrome</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">developmental disorders</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bowden, Kristin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berry-Kravis, Elizabeth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Patterson, Tiffany ELSEVIER</subfield><subfield code="t">NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS</subfield><subfield code="d">2016</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV01421802X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:65</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:1-13</subfield><subfield code="g">extent:13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pediatrneurol.2016.07.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.00</subfield><subfield code="j">Werkstoffkunde: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.32</subfield><subfield code="j">Werkstoffmechanik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">65</subfield><subfield code="j">2016</subfield><subfield code="h">1-13</subfield><subfield code="g">13</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
van Karnebeek, Clara D.M. |
spellingShingle |
van Karnebeek, Clara D.M. ddc 610 ddc 600 bkl 51.00 bkl 51.32 Elsevier neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future |
authorStr |
van Karnebeek, Clara D.M. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV01421802X |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 600 - Technology 690 - Buildings |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders Elsevier |
topic |
ddc 610 ddc 600 bkl 51.00 bkl 51.32 Elsevier neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders |
topic_unstemmed |
ddc 610 ddc 600 bkl 51.00 bkl 51.32 Elsevier neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders |
topic_browse |
ddc 610 ddc 600 bkl 51.00 bkl 51.32 Elsevier neurogenetic disorders Elsevier genetic diseases Elsevier therapy Elsevier fragile X syndrome Elsevier developmental disorders |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
k b kb e b k ebk |
hierarchy_parent_title |
NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS |
hierarchy_parent_id |
ELV01421802X |
dewey-tens |
610 - Medicine & health 600 - Technology 690 - Building & construction |
hierarchy_top_title |
NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV01421802X |
title |
Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future |
ctrlnum |
(DE-627)ELV024621870 (ELSEVIER)S0887-8994(16)30195-3 |
title_full |
Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future |
author_sort |
van Karnebeek, Clara D.M. |
journal |
NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS |
journalStr |
NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2016 |
contenttype_str_mv |
zzz |
container_start_page |
1 |
author_browse |
van Karnebeek, Clara D.M. |
container_volume |
65 |
physical |
13 |
class |
610 610 DE-600 610 VZ 600 690 VZ 51.00 bkl 51.32 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
van Karnebeek, Clara D.M. |
doi_str_mv |
10.1016/j.pediatrneurol.2016.07.010 |
dewey-full |
610 600 690 |
title_sort |
treatment of neurogenetic developmental conditions: from 2016 into the future |
title_auth |
Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future |
abstract |
Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. |
abstractGer |
Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. |
abstract_unstemmed |
Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 |
title_short |
Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future |
url |
https://doi.org/10.1016/j.pediatrneurol.2016.07.010 |
remote_bool |
true |
author2 |
Bowden, Kristin Berry-Kravis, Elizabeth |
author2Str |
Bowden, Kristin Berry-Kravis, Elizabeth |
ppnlink |
ELV01421802X |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth |
doi_str |
10.1016/j.pediatrneurol.2016.07.010 |
up_date |
2024-07-06T21:55:03.887Z |
_version_ |
1803868337747263488 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV024621870</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623174418.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pediatrneurol.2016.07.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016015000027.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV024621870</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0887-8994(16)30195-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.32</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">van Karnebeek, Clara D.M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">13</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neurogenetic developmental conditions represent a heterogeneous group of rare inherited disorders with neurological manifestation during development. Treatments for these conditions have largely been supportive; however, a number of treatments are emerging which target the underlying physiology and offer great potential. Our aim was to present a state-of-the-art overview of the current and potential causal treatments available or under development for neurogenetic developmental conditions.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">neurogenetic disorders</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">genetic diseases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">fragile X syndrome</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">developmental disorders</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bowden, Kristin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berry-Kravis, Elizabeth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Patterson, Tiffany ELSEVIER</subfield><subfield code="t">NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS</subfield><subfield code="d">2016</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV01421802X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:65</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:1-13</subfield><subfield code="g">extent:13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pediatrneurol.2016.07.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.00</subfield><subfield code="j">Werkstoffkunde: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.32</subfield><subfield code="j">Werkstoffmechanik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">65</subfield><subfield code="j">2016</subfield><subfield code="h">1-13</subfield><subfield code="g">13</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.4005013 |